"Why is it that patients who take prednisone, insulin...and a myriad of other medications daily or regularly to manage ...
The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...
The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...
Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...
The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.
For years, Texans living with conditions like PTSD, neuropathy, cancer and spasticity have had limited treatment options. Now ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
Neurologists in Ireland have revealed they are prescribing cannabis-based medicines for symptoms such as pain and spasticity ...
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...